V.A.C. GranuFoam Silver Large Dressing is barrier to bacterial penetration and may help reduce in...

FDA Device Recall #Z-0070-2015 — Class II — September 18, 2014

Recall Summary

Recall Number Z-0070-2015
Classification Class II — Moderate risk
Date Initiated September 18, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm KCI USA, Inc.
Location San Antonio, TX
Product Type Devices
Quantity 1090 pouches (109 boxes)

Product Description

V.A.C. GranuFoam Silver Large Dressing is barrier to bacterial penetration and may help reduce infection. Featuring SensaT.R.A.C. Technology REF M8275099/10 STERILE Single Use only Latex Free Rx Only.

Reason for Recall

A portion of the V.A.C. GranuFoam Silver Dressing M8275099/10 lot 50775977 was incorrectly manufactured with an incorrect expiry date on the sterile pouch. The correct expiry date of 2015-11 is on the case label, however the pouch label identifies the expiry date of 2016-11.

Distribution Pattern

The affected product was distributed to Mexico, Turkey, and United Arab Emirates only. The affected product was not distributed to the US.

Lot / Code Information

Lot Number 50775911

Other Recalls from KCI USA, Inc.

Recall # Classification Product Date
Z-1176-2025 Class II 3M V.A.C. VIA Negative Pressure Wound Therapy S... Jan 17, 2025
Z-1175-2025 Class II 3M Prevena Plus 125 Therapy Unit and System Kit... Jan 17, 2025
Z-0507-2025 Class II V.A.C. Ulta Therapy Unit REF CAPULTDEV01 & ULTD... Nov 5, 2024
Z-2542-2020 Class II ACTIV.A.C Therapy System; Model Numbers; US: 3... Jun 8, 2020
Z-2171-2017 Class II 1000 ml Canister (with Gel) for InfoV.A.C. and ... Apr 28, 2017

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.